Tazarotene Market Size, Share & Industry Analysis, By Form ( Foam, Cream, Gel ), By Application ( Psoriasis, Acne, Sun-damaged , Others ) and regional Forecast, 2024-2032

Tazarotene is a third generation treatment topical retinoid. It is a member of the acetylenic class of retenoids. It is generally used to treat skin diseases like psoriasis, sun damaged skin, and acne. It is generally sold in two concentrations of 0.05% and 0.01%. It is a retinoid prodrug which is converted into its active form by rapid esterification.

Increasing demand from cosmetic and pharmaceutical sector for tazarotene creams, foams, and gels for treating acne, sun-damaged skin and other skin problems shall drive the market. Additionally, increasing occurrence of skin diseases due to increasing pollution, high intake of junk food, and hectic lifestyle shall impact the market positively.

However, stringent regulations have been imposed by governmental authorities regarding the medications and their applications in several countries. This is expected to hinder the market growth.

Market Segmentation:

Based on form, the market is segmented into cream, foam, and gel. Based on application, the market is segmented into, sun-damaged skin, acne, psoriasis, and others.

From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Players Covered:

The global tazarotene market consists of global & regional players operating. Some of the key players in the market include BOC Sciences, TCI, HBCChem, Toronto Research Chemicals, Waterstone Technology, 3B Scientific, J & K scientific, Nanjing Chemlin Chemical, XiaoGan ShenYuan ChemPharm, Hangzhou Yuhao Chemical Technology and others.

Key Insights

• New Advancements in Production Technologies


• Key Trends in the Tazarotene Market


• New Product Launches, Expansions, Key Players


• Ranking of Key Players in the Market

Regional Analysis:

The market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to show significant growth attributed to the increasing expenditure on skincare. Europe is estimated to show generous growth attributed to the rise in disposable income and substantial spending on skincare products. Asia Pacific is estimated to show considerable growth due to the increasing prevalence of skin diseases. Latin America and Middle East & Africa is expected to show considerable growth by the end of the forecast period.

Segmentation

Tazarotene Industry Developments

• In June 2020, Ortho dermatologics of Bausch Inc., launched Arazlo, a tazarotene lotion with concentration of 0.045 % in the U.S.